You just read:

Aruvant Sciences Presents Data from Ongoing Clinical Study of Lentiviral Gene Therapy RVT-1801 for Sickle Cell Disease at 60th Annual Meeting of the American Society of Hematology

News provided by

Aruvant Sciences

Dec 03, 2018, 21:30 ET